A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/06 (2006.01) A61P 9/04 (2006.01)
Patent
CA 2614959
The present invention describes novel uses for inhibitors of the ubiquitin proteasome degradative pathway. In particular it describes methods for improving cardiac function, increasing alpha myosin levels in the heart, and increasing SERCA levels in the heart. The invention also provides methods for treating cardiac hypertrophy through inhibiton of the ubiquitin proteasome.
L'invention concerne de nouvelles utilisations d'inhibiteurs de la voie de dégradation ubiquitine-protéasome. L'invention se rapporte, en particulier, à des procédés qui permettent d'améliorer la fonction cardiaque, d'augmenter les niveaux de myosine alpha dans le coeur, et d'augmenter les niveaux de la SERCA dans le coeur. L'invention porte également sur des procédés qui permettent de traiter l'hypertrophie cardiaque en inhibant l'ubiquitine-protéasome.
Bush Erik
Gorczynski Rick
Koch Keith
Mckinsey Timothy A.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Myogen Inc.
LandOfFree
Use of inhibitors of the ubiquitin proteasome pathway for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of inhibitors of the ubiquitin proteasome pathway for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of inhibitors of the ubiquitin proteasome pathway for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1885735